Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2014, Article ID 276475, 2 pages
http://dx.doi.org/10.1155/2014/276475
Editorial

Insulin Resistance, Type 1 and Type 2 Diabetes, and Related Complications: Current Status and Future Perspective

1Department of Physiology, College of Medicine, University of Saskatchewan, 107 Wiggins Road, Saskatoon, SK, Canada S7N 5E5
2Division of Cardiology, Department of Medicine, Henry Ford Heart and Vascular Institute, 2799 West Grand Boulevard, Detroit, MI 48202-2689, USA
3Department of Pharmacology, Center for Integrative Medicine, Center for Molecular Medicine (CIMMBA), University of Florence, Viale Pieraccini 6, 50139 Florence, Italy

Received 12 February 2014; Accepted 12 February 2014; Published 18 March 2014

Copyright © 2014 Joseph Fomusi Ndisang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Hossain, B. Kawar, and M. El Nahas, “Obesity and diabetes in the developing world—a growing challenge,” The New England Journal of Medicine, vol. 356, no. 3, pp. 213–215, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. WHO, Obesity and overweight. Fact Sheet no. 311 in: World Health Organization, 2006.
  3. M. Mishra and J. F. Ndisang, “A critical and comprehensive insight on heme oxygenase and related products including carbon monoxide, bilirubin, biliverdin and ferritin in type-1 and type-2 diabetes,” Current Pharmaceutical Design, 2013. View at Google Scholar
  4. S. Tiwari and J. F. Ndisang, “The heme oxygenase system and type-1 diabetes,” Current Pharmaceutical Design, 2013. View at Google Scholar
  5. S. J. Cleland, B. M. Fisher, H. M. Colhoun, N. Sattar, and J. R. Petrie, “Insulin resistance in type 1 diabetes: what is “double diabetes” and what are the risks?” Diabetologia, vol. 56, no. 7, pp. 1462–1470, 2013. View at Publisher · View at Google Scholar
  6. N. J. Nokoff, M. Rewers, and M. Cree Green, “The interplay of autoimmunity and insulin resistance in type 1 diabetes,” Discovery Medicine, vol. 13, pp. 115–122, 2012. View at Google Scholar
  7. J. F. Ndisang and A. Jadhav, “The heme oxygenase system attenuates pancreatic lesions and improves insulin sensitivity and glucose metabolism in deoxycorticosterone acetate hypertension,” American Journal of Physiology: Regulatory Integrative and Comparative Physiology, vol. 298, no. 1, pp. R211–R223, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. J. F. Ndisang, N. Lane, and A. Jadhav, “Upregulation of the heme oxygenase system ameliorates postprandial and fasting hyperglycemia in type 2 diabetes,” American Journal of Physiology: Endocrinology and Metabolism, vol. 296, no. 5, pp. E1029–E1041, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Settin, R. El-Baz, A. Ismaeel, W. Tolba, and W. A. Allah, “Association of ACE and MTHFR genetic polymorphisms with type 2 diabetes mellitus: susceptibility and complications,” Journal of the Renin-Angiotensin-Aldosterone System, 2014. View at Google Scholar
  10. R. W. Schwenk, H. Vogel, and A. Schurmann, “Genetic and epigenetic control of metabolic health,” Molecular Metabolism, vol. 2, no. 4, pp. 337–347, 2013. View at Publisher · View at Google Scholar
  11. F. Miao, Z. Chen, S. Genuth et al., “Evaluating the role of epigenetic histone modifications in the metabolic memory of type 1 diabetes,” Diabetes, 2014. View at Publisher · View at Google Scholar
  12. J. H. O'Keefe , S. K. Bhatti, H. R. Patil, J. J. DiNicolantonio, S. C. Lucan, and C. J. Lavie, “Effects of habitual coffee consumption on cardiometabolic disease, cardiovascular health, and all-cause mortality,” Journal of the American College of Cardiology, vol. 62, no. 12, pp. 1043–1051, 2013. View at Publisher · View at Google Scholar
  13. I. Sandovici, C. M. Hammerle, S. E. Ozanne, and M. Constancia, “Developmental and environmental epigenetic programming of the endocrine pancreas: consequences for type 2 diabetes,” Cellular and Molecular Life Sciences, vol. 70, no. 9, pp. 1575–1595, 2013. View at Publisher · View at Google Scholar
  14. M. Murea, L. Ma, and B. I. Freedman, “Genetic and environmental factors associated with type 2 diabetes and diabetic vascular complications,” The Review of Diabetic Studies, vol. 9, pp. 6–22, 2012. View at Publisher · View at Google Scholar
  15. K. Hess and P. J. Grant, “Inflammation and thrombosis in diabetes,” Thrombosis and Haemostasis, vol. 105, supplement 1, pp. S43–S54, 2011. View at Publisher · View at Google Scholar · View at Scopus